Andrea T. Kondo

Dr. Andrea T. Kondo


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2020 in Cells
Verified
Journal Article
Open access
PDF file
Fernando Anselmo de OliveiraFernando Anselmo de Oliveira
Fernando Anselmo de Oliveira
Mariana Penteado NucciMariana Penteado Nucci
Mariana Penteado Nucci
Igor Salerno FilgueirasIgor Salerno Filgueiras
Igor Salerno Filgueiras
JFJoão M. Ferreira
João M. Ferreira
LNLeopoldo P. Nucci
Leopoldo P. Nucci
Lionel F. GamarraLionel F. Gamarra
Lionel F. Gamarra
The hematopoietic stem cell engraftment depends on adequate cell numbers, their homing, and the subsequent short and long-term engraftment of these cells in the niche. We performed a systematic review of the methods employed to track hematopoietic reconstitution using molecular imaging. We searched articles indexed, published prior to January 2020, in PubMed, Cochrane, and Scopus with the following keyword sequences: (Hematopoietic Stem Cell OR Hematopoietic Progenitor Cell) AND (Tracking OR Homing) AND (Transplantation). Of 2191 articles identified, only 21 articles were included in this review, after screening and eligibility assessment. The cell source was in the majority of bone marrow from mice (43%), followed by the umbilical cord from humans (33%). The labeling agent had the follow distribution between the selected studies: 14% nanoparticle, 29% radioisotope, 19% fluorophore, 19% luciferase, and 19% animal transgenic. The type of graft used in the studies was 57% allogeneic, 38% xenogeneic, and 5% autologous, being the HSC receptor: 57% mice, 9% rat, 19% fish, 5% for dog, porcine and salamander. The imaging technique used in the HSC tracking had the following distribution between studies: Positron emission tomography/single-photon emission computed tomography 29%, bioluminescence 33%, fluorescence 19%, magnetic resonance imaging 14%, and near-infrared fluorescence imaging 5%. The efficiency of the graft was evaluated in 61% of the selected studies, and before one month of implantation, the cell renewal was very low (less than 20%), but after three months, the efficiency was more than 50%, mainly in the allogeneic graft. In conclusion, our review showed an increase in using noninvasive imaging techniques in HSC tracking using the bone marrow transplant model. However, successful transplantation depends on the formation of engraftment, and the functionality of cells after the graft, aspects that are poorly explored and that have high relevance for clinical analysis.

29 April 2022 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
MRMarina Larissa Vettorello Ramires
Marina Larissa Vettorello Ramires
MLManoela Fidelis Batista Leite
Manoela Fidelis Batista Leite
DLDaniel Zu Yow Lo
Daniel Zu Yow Lo
LSLeonardo Bonilla da Silveira
Leonardo Bonilla da Silveira
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
MGMiguel Angelo Goes
Miguel Angelo Goes
Objective The objective of the present study is to evaluate the association of red blood cell distribution width with acute kidney injury in sepsis. Methods This is a retrospective study of 849 critically ill patients with sepsis in intensive care unit. Demographic data, renal function, inflammation, complete blood count, and acid-base parameters were compared between acute kidney injury and non-acute kidney injury groups. Therefore, a multivariate analysis was performed to observe independent predictive factors. Results Comparatively, higher levels of

13 April 2022 in Ophthalmic Genetics
Verified
Journal Article
Closed access
JSJuliana Maria Sallum
Juliana Maria Sallum
JGJuliana Aparecida Preto de Godoy
Juliana Aparecida Preto de Godoy
AKAndrea T. Kondo
Andrea T. Kondo
JKJose Mauro Kutner
Jose Mauro Kutner
HVHuber Vasconcelos
Huber Vasconcelos
AMAndre Maia
Andre Maia
To report the first Brazilian patient with RPE65 deficiency-inherited retinal dystrophy (RPE65-IRD) treated with voretigene neparvovec-rzyl (VN).An adult patient with Leber congenital amaurosis-2 w...

30 March 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CDCamila Dermínio Donadel
Camila Dermínio Donadel
BPBruno Garcia Pires
Bruno Garcia Pires
NANathália Cristine André
Nathália Cristine André
TCThalita Costa
Thalita Costa
MOMaristela Delgado Delgado Orellana
Maristela Delgado Delgado Orellana
GSGil Cunha De Santis
Gil Cunha De Santis
Background: Steroid-refractory acute graft-vs.-host disease (SR-aGVHD) is a complication of allogeneic hematopoietic stem cell transplantation with a dismal prognosis and for which there is no consensus-based second-line therapy. Ruxolitinib is not easily accessible in many countries. A possible therapy is the administration of mesenchymal stromal cells (MSCs). Methods: In this retrospective study, 52 patients with severe SR-aGVHD were treated with MSCs from umbilical cord (UC-MSCs) in nine institutions. Results: The median (range) age was 12.5 (0.3–65) years and the mean ± SD dose (×106/kg) was 4.73 ± 1.3 per infusion (median of four infusions). Overall (OR) and complete response (CR) rates on day 28 were 63.5% and 36.6%, respectively. Children (n = 35) had better OR (71.5% vs. 47.1%, p = 0.12), CR (48.6% vs. 11.8%, p = 0.03), overall survival (p = 0.0006), and relapse-free survival (p = 0.0014) than adults (n = 17). Acute adverse events (all of them mild or moderate) were detected in 32.7% of patients, with no significant difference in children and adult groups (p = 1.0). Conclusions: UC-MSCs are a feasible alternative therapy for SR-aGVHD, especially in children. The safety profile is favorable.

29 June 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Fernando Anselmo de OliveiraFernando Anselmo de Oliveira
Fernando Anselmo de Oliveira
Mariana Penteado NucciMariana Penteado Nucci
Mariana Penteado Nucci
JMJavier Bustamante Mamani
Javier Bustamante Mamani
AAArielly da Hora Alves
Arielly da Hora Alves
GRGabriel N. A. Rego
Gabriel N. A. Rego
Lionel F. GamarraLionel F. Gamarra
Lionel F. Gamarra
This study proposes an innovative way to evaluate the homing and tracking of hematopoietic stem cells from young and old mice labeled with SPIONNIRF-Rh conjugated with two types of fluorophores (NIRF and Rhodamine), and their grafting by bioluminescence (BLI) in a bone marrow transplant (BMT) model. In an in vitro study, we isolated bone marrow mononuclear cells (BM-MNC) from young and old mice, and analyzed the physical–chemical characteristics of SPIONNIRF-Rh, their internalization, cell viability, and the iron quantification by NIRF, ICP-MS, and MRI. The in vivo study was performed in a BMT model to evaluate the homing, tracking, and grafting of young and old BM-MNC labeled with SPIONNIRF-Rh by NIRF and BLI, as well as the hematological reconstitution for 120 days. 5FU influenced the number of cells isolated mainly in young cells. SPIONNIRF-Rh had adequate characteristics for efficient internalization into BM-MNC. The iron load quantification by NIRF, ICP-MS, and MRI was in the order of 104 SPIONNIRF-Rh/BM-MNC. In the in vivo study, the acute NIRF evaluation showed higher signal intensity in the spinal cord and abdominal region, and the BLI evaluation allowed follow-up (11–120 days), achieving a peak of intensity at 30 days, which remained stable around 108 photons/s until the end. The hematologic evaluation showed similar behavior until 30 days and the histological results confirm that iron is present in almost all tissue evaluated. Our results on BM-MNC homing and tracking in the BMT model did not show a difference in migration or grafting of cells from young or old mice, with the hemogram analysis trending to differentiation towards the myeloid lineage in mice that received cells from old animals. The cell homing by NIRF and long term cell follow-up by BLI highlighted the relevance of the multimodal nanoparticles and combined techniques for evaluation.

13 November 2024 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
JAJúlia Teixeira Cottas de Azevedo
Júlia Teixeira Cottas de Azevedo
JGJuliana Aparecida Preto de Godoy
Juliana Aparecida Preto de Godoy
CSCláudia de Souza
Cláudia de Souza
MSMicheli Severo Sielski
Micheli Severo Sielski
LCLarissa Leggieri Coa
Larissa Leggieri Coa
RPRaquel de Melo Alves Paiva
Raquel de Melo Alves Paiva
Natural Killer cells are immune leukocytes required for responses against tumor cells and virus-infected cells. In the last decade, natural killer cells have emerged as promising tools in cancer therapy, and clinical studies on patients treated with natural killer cells have revealed increased rates of disease-free survival. In this article, we review results from the major clinical trials that have used natural killer cells for cancer treatment, including their global distribution. We also discuss the major mechanisms of natural